Trial intelligence / Profile preview

Tamsulosin OCAS vs tamsulosin MR vs placebo for lower urinary tract symptoms

IRCT20100817004582N8Phase 4Completed

Sponsor
Urology Research Centre
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tamsulosin in Micturition disorder (3 arms), sponsored by Urology Research Centre. Primary endpoints: Efficacy in improving lower urinary tract symptoms and Safety and tolerability. Started Jan 2018; status: completed.

02

Drugs

tamsulosin
03

Conditions

Micturition disorder

Beyond the preview

Go deeper on IRCT20100817004582N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100817004582N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call